Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...
Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.
19h
The Nation UAE on MSNPanic in Taunsa Sharif after 50 children test HIV/AIDS positiveIn an unprecedented crisis, a small town called Taunsa Sharif, located in South Punjab, is grappling with an alarming outbreak of HIV/AIDS among minor children aged from nine months to 10 years, with ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...
But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.
Fiji health authorities are scrambling to stem an outbreak of HIV, as growing meth use and alarming needle-sharing trends accelerate the spread of the virus.
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results